MedPath

desoximetasone

Desoximetasone Ointment USP, 0.25%

Approved
Approval ID

4025ed23-a591-4754-8dbb-4da18f49a3e3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 8, 2022

Manufacturers
FDA

Padagis Israel Pharmaceuticals Ltd

DUNS: 600093611

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Desoximetasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code45802-496
Application NumberANDA077770
Product Classification
M
Marketing Category
C73584
G
Generic Name
Desoximetasone
Product Specifications
Route of AdministrationTOPICAL
Effective DateJuly 8, 2019
FDA Product Classification

INGREDIENTS (3)

DESOXIMETASONEActive
Quantity: 2.5 mg in 1 g
Code: 4E07GXB7AU
Classification: ACTIB
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
MEDIUM-CHAIN TRIGLYCERIDESInactive
Code: C9H2L21V7U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

desoximetasone - FDA Drug Approval Details